The Leukemia That Kept Vanishing With Every Infection
It happened — and nature accounts for it.
The account
An 80-year-old woman with untreated acute myeloid leukemia watched her cancer retreat from her blood three separate times, each in step with a different serious infection — a mycobacterium, an aspergillus fungus, and an E. coli bloodstream infection. She received no chemotherapy, yet survived more than two years past the expected end-stage horizon. Her doctors published it as a documented case of repeated spontaneous remission, and pointed to the immune system, jolted awake by infection, as the likely engine. It is one of the rarest patterns in all of oncology — and the mechanism is real but only half-understood.
Read the full account →Collapse the account ↑
An 80-year-old woman with untreated acute myeloid leukemia watched her cancer retreat from her blood three separate times, each in step with a different serious infection — a mycobacterium, an aspergillus fungus, and an E. coli bloodstream infection. She received no chemotherapy, yet survived more than two years past the expected end-stage horizon.
The case was documented at Kagawa University Hospital in Kagawa Prefecture, Japan. Her diagnosis was cytogenetically confirmed: acute myeloid leukemia with myelodysplasia-related changes, carrying a del(5q) marker. Each time she developed one of the three independent infections, serial blood counts recorded leukemic blasts clearing from her peripheral blood, with her blood-cell production recovering and no transfusions needed. Across the episodes, the del(5q) clone shrank from 6 of 20 cells to 1 of 20.
Her doctors published the case in BMC Infectious Diseases in 2023 as a documented instance of repeated spontaneous remission. In their account they pointed to the immune system, jolted awake by infection, as the likely engine — framing it as "an immunological antileukemic effect of systemic infections," which they described as "a limited" effect. The remissions were temporary, residual disease persisted, and the leukemia was never cured.
The events were tracked from August 2020 through December 2021, with the patient's survival followed beyond two years.
Reviewer Notes
We weigh a claim on two things, kept separate from the story above.
Assessed by Miracles Jar AI
Genuinely rare and well-documented, but with a credible (if incomplete) natural mechanism — leans explained.
The verdict: Genuinely rare and well-documented, but with a credible (if incomplete) natural mechanism — leans explained. No prayer, shrine, or devotional element is reported; this is a medical anomaly entry. Grading it honestly does not produce a high score on the miracle meter, and that integrity matters.
Why this earns a place in the jar
The facts are about as solid as case reports get: a peer-reviewed paper in BMC Infectious Diseases (2023), a single academic hospital, a cytogenetically confirmed diagnosis (AML with myelodysplasia-related changes, del(5q) marker), and serial blood counts showing leukemic blasts clearing after each of three independent infections, with hematopoiesis recovering and no transfusions needed. The del(5q) clone shrank from 6/20 to 1/20 cells across the episodes. No chemotherapy was given, and the patient outlived the median end-stage survival by more than two years. Documentation strength is high.
Rarity and repetition
Spontaneous remission of AML is one of the most uncommon events in oncology — fewer than 100 adult cases are reported in the entire medical literature, and a systematic review (Rashidi & Fisher, Leukemia & Lymphoma, 2015) counted only 46 by modern diagnostic criteria as of 2014. For one patient to remit not once but three times, each tied to a different pathogen, is exceptional even within that tiny club. That is a real anomaly, not a reporting artifact.
The leading natural account
There is an established (if poorly characterized) phenomenon in which systemic febrile infection activates innate and adaptive immunity — NK cells, cytotoxic T-lymphocytes, and inflammatory cytokines like IL-1, IL-6, TNF-α — transiently suppressing leukemic clones. Across the literature, roughly 90% (the systematic review puts it at ~91%) of AML spontaneous remissions occur in the setting of infection and fever, exactly as here; median remission runs ~5 months. The authors themselves frame this as "an immunological antileukemic effect of systemic infections" and call it "a limited" effect. The remissions were temporary, residual disease persisted, and the cancer was never cured. This is a low-probability outcome of known biology, not a suspension of it.
Where the meter lands
The strength of the case is also its honest ceiling: the mechanism is real but only partially worked out, the effect is documented and reproducible-within-the-patient, and nothing in the record points beyond immunology. This is interesting and rare, but explainable. Reporting it as anything more would be the positivity bias the brief warns against.
Evidence ledger
- *Authentic / strong:* Diagnosis was objective and cytogenetically confirmed (AML with myelodysplasia-related changes, del(5q) clone), not a clinical impression — a hard laboratory anchor ruling out misdiagnosis as the explanation for the recovery.
- *Authentic / strong:* Leukemic blasts cleared from peripheral blood and pancytopenia improved after each of three independent infections, with no chemotherapy given; del(5q) clone declined from 6/20 to 1/20 cells.
- *Authentic / moderate:* Patient survived >2 years beyond median survival for end-stage AML — striking longevity for an untreated aggressive leukemia in an 80-year-old.
- *Authentic / moderate:* Repetition across three different pathogens (mycobacterium, aspergillus, E. coli) is exceptional even among the <100 reported AML spontaneous remissions; single-patient reproducibility makes coincidence a weaker explanation.
- *Natural / strong:* A well-described mechanism exists — infection/fever-triggered immune activation (NK cells, cytotoxic T-cells, IL-1/IL-6/TNF-α) transiently suppressing leukemic clones; ~90% of AML spontaneous remissions occur with febrile infection, and the authors endorse this mechanism for their own case.
- *Natural / strong:* Remissions were temporary and incomplete — residual disease persisted, the leukemia was never cured, and the authors explicitly call the effect "limited."
- *Neutral / moderate:* Single case report from one institution; no independent medical-bureau adjudication. Documentation is strong for the genre but not multi-center or externally verified beyond peer review.
Sources. (1) Imataki O, Ishida T, Kida JI, Uemura M, Fujita H, Kadowaki N. "Repeated spontaneous remission of acute myeloid leukemia in response to various infections: a case report." BMC Infectious Diseases, 2023. BMC Infect Dis 23(1):215. DOI 10.1186/s12879-023-08108-z. Primary full-text. https://pmc.ncbi.nlm.nih.gov/articles/PMC10080930/ (2) Same paper, PubMed record (Imataki O, et al., 2023), confirming authors, journal, DOI, and the authors' framing of the mechanism as proposed (immune-mediated), not established. https://pubmed.ncbi.nlm.nih.gov/37024850/ (3) Rashidi A, Fisher SI. "Spontaneous remission of acute myeloid leukemia." Leukemia & Lymphoma, 2015. Secondary systematic review establishing rarity (<100 adult cases ever; 46 by modern criteria; ~91% associated with febrile infection; median remission ~5 months). https://pubmed.ncbi.nlm.nih.gov/25284494/
Evidence ledger — what the verdict rests on
Diagnosis was objective and cytogenetically confirmed (AML with myelodysplasia-related changes, del(5q) clone), not a clinical impression.
Hard laboratory anchor — rules out misdiagnosis as the explanation for the 'recovery.'
Leukemic blasts cleared from peripheral blood and pancytopenia improved after each of three independent infections, with no chemotherapy given.
Documented by serial blood counts; the del(5q) clone declined from 6/20 to 1/20 cells across episodes.
Patient survived >2 years beyond the median survival for end-stage AML.
Striking longevity for an untreated aggressive leukemia in an 80-year-old.
Repetition across three different pathogens (mycobacterium, aspergillus, E. coli) is exceptional even among the <100 reported AML spontaneous remissions.
Single-patient reproducibility makes coincidence a weaker explanation.
A well-described natural mechanism exists: infection/fever-triggered immune activation (NK cells, cytotoxic T-cells, IL-1/IL-6/TNF-α) transiently suppressing leukemic clones.
~90% of AML spontaneous remissions occur with febrile infection; the authors endorse this mechanism for their own case.
Remissions were temporary and incomplete — residual disease persisted and the leukemia was never cured.
Authors explicitly call the effect 'limited.' Pattern fits a low-probability outcome of known biology, not a suspension of it.
Single case report from one institution; no independent medical-bureau adjudication.
Documentation is strong for the genre but is not multi-center or externally verified beyond peer review.
What would raise this score: Long-term follow-up documenting permanence, in a condition with a near-zero spontaneous-resolution base rate, would raise the meter.
What would lower it: A documented relapse, or case literature showing the condition fluctuates or remits on its own, would move it down.
How this works
We keep two questions apart on purpose — so a thin record can’t make an impossible thing look proven, and a strong record can’t dress up an ordinary one as a miracle. First: Could nature explain it? (taking the account as true for the moment.) The question is whether nature could produce this at all — assuming, for the moment, the events are true as described. Second: is there real evidence it happened? A claim only stands out when both hold up — and we never call anything certain either way. How ratings work →
The natural explanation
The leading natural account for this case is spontaneous remission & the body's own recovery. Read what it explains — and where it stops.
Sources
Tagged by proximity to the event. Primary sources are direct or contemporaneous; tertiary are downstream retellings.
- 1.Primaryacademic
Full-text primary case report. BMC Infect Dis 23(1):215. DOI 10.1186/s12879-023-08108-z. Documents three infection-associated remissions, del(5q) clone tracking, >2-year survival without chemotherapy.
- 2.Primaryacademic
Citation + verbatim abstract confirming authors, journal, DOI, and the authors' framing of mechanism as proposed (immune-mediated), not established.
- 3.Secondaryacademic
Establishes rarity: <100 adult cases ever; 46 by modern criteria; ~91% associated with febrile infection; median remission ~5 months. Corroborates both the rarity and the leading natural mechanism.
Cases like this
Nearest on the map — similar in how miraculous they’d be, and how strong the evidence is.